Nuveen Asset Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$12,865,312
+41.5%
830,556
+45.6%
0.00%
+33.3%
Q1 2024$9,094,073
+101.3%
570,519
+112.3%
0.00%
+200.0%
Q4 2023$4,517,048
+46.5%
268,712
+1.8%
0.00%0.0%
Q3 2023$3,084,232
-11.5%
263,835
+1.8%
0.00%0.0%
Q2 2023$3,483,702
+79309.7%
259,204
-2.0%
0.00%
-50.0%
Q1 2023$4,387
-74.5%
264,571
-71.4%
0.00%
-71.4%
Q4 2022$17,221
-99.9%
925,877
-33.1%
0.01%0.0%
Q3 2022$17,754,000
+74.7%
1,383,789
-4.6%
0.01%
+75.0%
Q2 2022$10,162,000
+85.4%
1,449,757
+107.6%
0.00%
+100.0%
Q1 2022$5,480,000
+17.0%
698,181
-4.2%
0.00%
+100.0%
Q4 2021$4,683,000
+15.6%
728,934
-9.1%
0.00%0.0%
Q3 2021$4,052,000
-22.6%
802,283
-11.9%
0.00%
-50.0%
Q2 2021$5,238,000
+29.5%
910,965
+3.8%
0.00%
+100.0%
Q1 2021$4,045,000
+32.1%
877,481
-4.3%
0.00%0.0%
Q4 2020$3,063,000
+168.9%
916,829
+139.0%
0.00%
Q3 2020$1,139,000
-35.4%
383,547
+0.5%
0.00%
-100.0%
Q2 2020$1,763,000
+14.6%
381,637
-4.5%
0.00%0.0%
Q1 2020$1,538,000
-80.9%
399,418
-81.4%
0.00%
-66.7%
Q4 2019$8,061,000
+278.6%
2,149,533
+436.1%
0.00%
+200.0%
Q3 2019$2,129,000
+40.5%
400,942
+1.6%
0.00%0.0%
Q2 2019$1,515,000394,5650.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders